Search Results for “Clinical Trial” – Page 30 – media

Gout Treatment – Shift from Phase 2 to Phase 3 Trial

Previous interim data reported negative results due to which the stock value of Selecta Biosciences dropped down at once by 20% in premarket trading. It was then recovered in a remarkable manner by touching the never seen before peak level.
- Source: FierceBiotech
- 509
- June 21, 2018
Clinical Trials gout
Calliditas Therapeutics Files to Raise $75 M for Kidney Disease Trial

Calliditas Therapeutics is planning to raise $75 million through an Initial Public Offering in Sweden. The new investment capital will help Calliditas fund a phase 3 clinical trial of autoimmune kidney disease anticipated to start later this year.
- Source: Fierce Biotech
- 724
- June 15, 2018
chronic kidney disease Clinical Trials funding
IPO Filed by Translate for Undertaking Fibrosis Treatment Trial

An IPO for raising USD 115 million from public investors has been filed by Translate Bio. Proceeds garnered from the IPO will be used by Translate to trial an mRNA candidate designed to allow cystic fibrosis patients produce CTFR proteins.
- Source: Ddu
- 574
- June 6, 2018
Clinical Trials cystic fibrosis
New Oncology Clinical Collaboration between Nektar and Takeda to Evaluate Combination of NKTR-214, a CD122-biased Agonist, and TAK-659, a Dual SYK and FLT-3 Inhibitor, in Liquid and Solid Tumors

New collaboration to explore the potential clinical benefits of two novel and complementary immuno-oncology mechanisms
- Source: prnewswire
- 665
- May 8, 2018
multiple cancer TAK-659 Takeda
Urotronic gets OK for advanced trial to treat narrowed urethras

Plymouth-based medical device maker Urotronic is ramping up clinical research on its Optilume drug-coated balloon to treat men with narrowed urethras, accelerating the data-gathering process for its novel device.
- Source: StarTribune
- 1,911
- April 26, 2018
FDA medical device medtech Researches
Autolus announces license agreement with UCL Business PLC for clinical-stage product candidate in development for the treatment of B-cell malignancies

- A CD19 CAR with novel targeting properties designed to reduce cytokine release syndrome –
- Source: autolus
- 579
- April 25, 2018
B-cell malignancies Market Views T-cell therapies
UCSD launching pilot trial of glucose-sensing ‘tattoo’

Researchers from the University of California San Diego have developed a low-cost, single-use tattoo-like wearable that measures the user’s glucose levels. According to a release from the institution, this noninvasive technology will be at the center of a newly announced pilot clinical trial designed to test the accuracy and acceptability of the tattoos.
- Source: MobiHealthNews
- 597
- April 25, 2018
blood glucose Researches
NEJM editorial slams design of GSK’s pivotal trial of 3-in-1 COPD drug Trelegy

GSK is shifting resources towards key therapeutic classes, including respiratory disease.
- Source: fiercepharma.
- 594
- April 24, 2018
Company Insight GSK respiratory disease Trelegy Ellipta
How do Clinical Wearables Impact Patient Care and Quality of Life?

Health technology and clinical wearables are hot topics in the healthcare and pharmaceutical industries. They are creating waves of excitement and talking points for debate, while also topping many of the healthcare trends of this year.
- Source: Hit Consultant
- 1,019
- April 10, 2018
Market Views mHealth wearables
Calorie restriction trial in humans suggests benefits for age-related disease

One of the first studies to explore the effects of calorie restriction on humans showed that cutting caloric intake by 15% for 2 years slowed aging and metabolism and protected against age-related disease. The study, which will appear March 22 in the journal Cell Metabolism, found that calorie restriction decreased systemic oxidative stress, which has been tied to age-related neurological conditions such as Alzheimer's and Parkinson's diseases, as well as cancer, diabetes, and others.
- Source: sciencedaily
- 571
- April 2, 2018
aging calorie restriction metabolism Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.